Erik Harris - Oct 3, 2024 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
/s/ Sanjay Subramanian, as attorney-in-fact for Erik Harris
Stock symbol
INZY
Transactions as of
Oct 3, 2024
Transactions value $
$0
Form type
4
Date filed
10/7/2024, 04:37 PM
Previous filing
Jun 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock Option (right to buy) Award $0 +56K $0.00 56K Oct 3, 2024 Common Stock 56K $5.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 3, 2024. The shares underlying the option are scheduled to vest in equal monthly installments from October 3, 2024 through October 3, 2027